FDA Warns Online Vendors to Stop Selling Unapproved Weight-Loss Drugs
The FDA on Tuesday published letters warning two online vendors to stop selling unapproved versions of semaglutide and tirzepatide.
The FDA on Tuesday published letters warning two online vendors to stop selling unapproved versions of semaglutide and tirzepatide.
Dr Arnold B. Alper, Jr, discusses challenges in C3 glomerulopathy (C3G) diagnosis.
“Early HS can mimic an intense folliculitis or furuncles that can sometimes be caused by Staphylococcus infections,” Sayed said.
This summary covers the management of acne in primary care, including advice on treatments and the impact on mental health and wellbeing
Warning letters to PCPs regarding overprescribing of antipsychotics for patients with dementia were associated with a decrease in prescriptions.
Families may feel more comfortable requesting food, housing, and other assistance if they don’t first need to disclose socioeconomic hardships.
The diabetes/weight loss drug semaglutide is associated with a significantly greater risk for repeat operations in patients with diabetes who require lumbar surgery.
Dr Roger Henderson provides seven top tips for primary care practitioners on the recognition, assessment, and management of this chronic autoimmune condition
Are you screening all adults for viral hepatitis, as recommended by the Centers for Disease Control and Prevention (CDC)? Join 2 experts in a discussion…
Dr Claire Davies identifies seven key learning points for primary care on managing long-term effects of COVID-19
Cardiology and nephrology experts present insights into the associations between ASCVD and CKD, inflammation, and potential for anti-inflammatory therapies.